NCT00384930 - Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia | Biotech Hunter

Enrollment

1,058

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2008

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

tadalafil

2.5 mg tadalafil tablet by mouth once a day for twelve weeks.

DRUG

tadalafil

5 mg tadalafil tablet by mouth once a day for twelve weeks.

DRUG

tadalafil

10 mg tadalafil tablet by mouth once a day for twelve weeks.

DRUG

tadalafil

20 mg tadalafil tablet by mouth once a day for twelve weeks.

DRUG

placebo

Placebo tablet taken by mouth one a day for twelve weeks

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Greenwood